Real-time enrollment status for this hidradenitis suppurativa clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT06603077 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Hidradenitis Suppurativa |
| Phase | Clinical Trial |
| Target Enrollment | 222 participants |
| Active Locations | 31 sites in the US |
| Sponsor | Avalo Therapeutics, Inc. |
| Last Updated on CT.gov | November 13, 2025 (Nov 13, 2025) |
As of March 2, 2026: Clinical trial NCT06603077 is currently active_not_recruiting participants. This clinical trial study for hidradenitis suppurativa is not currently accepting new participants at 31 locations across the United States. The study is sponsored by Avalo Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06603077 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 31 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06603077 was last updated Nov 13, 2025 (November 13, 2025). HelloStudys verifies this status automatically.